NCT05658549View on ClinicalTrials.gov

Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions

COVID-19

Interventions

DRUG

N-acetyl cysteine

N-acetyl cysteine dosage 600 mg and 1200 mg

Trial Locations (1)

57161

Universitas Sebelas Maret Hospital, Sukoharjo

All Listed Sponsors

lead

Universitas Sebelas Maret

OTHER